ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 141,46
0,00%
Dow Jones
39 872,99
0,17%
DAX
18 726,76
-0,21%
Brent Oil
82,115
-0,40%
Bitcoin
69 862,63
-0,38%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Canadá
  5. TSXV
  6. Aequus Pharmaceuticals Inc (AQS)

  7. Aequus Pharmaceuticals Inc (AQS) Actualités

AQS

Aequus Pharmaceuticals (AQS)

Aequus Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:TSXV:AQS
DateHeureSourceTitreSymboleSociété
13/07/202222h13PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - AQSTSXV:AQSAequus Pharmaceuticals Inc
13/07/202222h11PR Newswire (Canada)IIROC Trading Resumption - AQSTSXV:AQSAequus Pharmaceuticals Inc
10/05/202214h15PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - AQSTSXV:AQSAequus Pharmaceuticals Inc
10/05/202214h13PR Newswire (Canada)IIROC Trading Halt - AQSTSXV:AQSAequus Pharmaceuticals Inc
02/05/202218h20PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - AQS.WTTSXV:AQSAequus Pharmaceuticals Inc
02/05/202218h17PR Newswire (Canada)IIROC Trading Halt - AQS.WTTSXV:AQSAequus Pharmaceuticals Inc
02/05/202215h01PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - AQS.DBTSXV:AQSAequus Pharmaceuticals Inc
02/05/202214h58PR Newswire (Canada)IIROC Trading Halt - AQS.DBTSXV:AQSAequus Pharmaceuticals Inc
06/08/202017h08PR Newswire (Canada)Aequus Completes C$2.5 million Equity FinancingTSXV:AQSAequus Pharmaceuticals Inc
28/07/202014h22PR Newswire (Canada)Aequus Announces "Best Efforts" Public OfferingTSXV:AQSAequus Pharmaceuticals Inc
05/03/201815h06PR Newswire (Canada)Aequus and Ehave Enter Into Collaboration Agreement for Comprehensive Patient Data Management in Clinical Trials of Medical C...TSXV:AQSAequus Pharmaceuticals Inc
11/01/201812h00PR Newswire (Canada)CannaRoyalty and Aequus Pharmaceuticals Announce Joint Venture to Develop and Commercialize Cannabis-Based Therapies Targetin...TSXV:AQSAequus Pharmaceuticals Inc
28/09/201714h30PR Newswire (Canada)Ehave Highlights Recent Developments and Corporate Strategy in Updated Letter to ShareholdersTSXV:AQSAequus Pharmaceuticals Inc
03/03/201715h40PR Newswire (Canada)Aequus Announces Upsizing of Previously Announced Bought Deal of Units to $4.5 MillionTSXV:AQSAequus Pharmaceuticals Inc
02/03/201722h28PR Newswire (Canada)Aequus Announces $3 Million Bought Deal FinancingTSXV:AQSAequus Pharmaceuticals Inc
21/02/201501h25PR Newswire (Canada)Aequus Pharmaceuticals Becomes Reporting IssuerTSXV:AQSAequus Pharmaceuticals Inc
 Showing the most relevant articles for your search:TSXV:AQS

Dernières Valeurs Consultées

NYSE
NKE
Nike
EU
CS
Axa
NASDAQ
GOOGL
Alphabet
EU
HO
Thales
EU
CAP
Capgemini
NYSE
MRK
Merck
EU
ML
Michelin
NYSE
MCD
McDonalds
NASDAQ
NVDA
NVIDIA
EU
ACA
Credit Agricole
EU
MC
Lvmh Moet Hennessy Louis...
EU
DG
Vinci
EU
BN
Danone
USI
USTECH100
US Tech 100
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés